Identification and management of difficult stroke and TIA syndromes

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue SUPPL. 1, 2001, Pages 117-122

  Brown, Martin M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345989837     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.suppl_1.i17     Document Type: Article

References (25)

1. Blight A, Pereira AC, Brown MM. A single consultation cerebrovascular clinic is cost effective in the management of transient ischaemic attack and minor stroke. J R Coll Physicians Lond 2000;34:452-5.
2. Russell RW, Page NG. Critical perfusion of brain and retina. Brain 1983;106:419-34.
3. Fisher CM. Late-life migraine accompaniments - further experience. Stroke 1986;17:1033-42.
4. Hodges JR, Warlow CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neurol Neurosurg Psychiatry 1990;53:834-43.
5. Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998;29:1888-93.
6. Duke RJ, Bloch RF, Turpie AG, et al. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med 1986;105:825-8.
7. Haley Jr EC, Kassell NF, Torner JC. Failure of heparin to prevent progression in progressing ischaemic infarction. Stroke 1988;19:10-14.
8. Pereira AC, Brown MM. Aspirin or heparin in acute stroke. Br Med Bull 2000;56:413-21. Anticoagulation treatment for acute ischaemic stroke is reviewed in this volume of the British Medical Bulletin, which contains many other up to date reviews on stroke treatment and is highly recommended.
9. Carolei A, Marini C, Ferranti E, et al. A prospective study of cerebral ischaemia in the young. Analysis of pathogenic determinants. The National Research Council study group. Stroke 1993;24:362-7.
10. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992;31:391-8.
11. Welch KMA, Tatemichi TK, Mohr JP. Migraine and stroke. In: Barnett HJM, Mohr JP, Stein BM, et al, eds. Stroke: pathophysiology, diagnosis and management, 3rd ed. Philadelphia: Churchill Livingstone, 1998: 845-67. A comprehensive review of the whole problem of migraine and stroke In one of the major textbooks of stroke.
12. Suzuki J, Kodama N. Moyamoya disease - a review. Stroke 1983;14:104-9.
13. Ferro JM. Vasculitis of the central nervous system. J Neurol 1998;245:766-76.
14. Hall S, Buchbinder R. Takayasu's arteritis. Rheum Dis Clin North Am 1990;16:411-22.
15. Brown MM, Swash M. Systemic lupus erythematosus. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology, revised series, vascular diseases part III, vol 55. Amsterdam: Elsevier Science Publishers, 1989:369-85.
16. Montalban J, Codina A, Ordi J, et al. Antiphospholipid antibodies in cerebral ischemia. Stroke 1991;22:750-3.
17. Tourbah A, Piette JC, Iba-Zizen MT, et al. The natural course of cerebral lesions in Sneddon syndrome. Arch Neurol 1997;54:53-60.
18. Susac JO. Susac's syndrome: the triad of microangiopathy of the brain and retina with hearing loss in young women. Neurology 1994;44:591-3.
19. Martinelli I, Landi G, Merati G, et al. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost 1996;75:393-4.
20. Autore C, Cartoni D, Piccininno M. Multiplane transesophageal echocardiography and stroke Am J Cardiol 1998;81:79G-81G.
21. Glass J, Hochberg FH, Miller DC. Intravascular lymphomatosis. A systemic disease with neurologic manifestations. Cancer 1993;71:3156-64.
22. McCabe DJH, Brown MM. Prevention of ischaemic stroke - antiplatelets. Br Med Bull 2000;56:510-25.
23. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-62. This study convincingly established the benefits of anticoagulation after stroke and TIA in patients with atrial fibrillation.
24. The Stroke Prevention in Reversible Ischaemia Trial (SPIRIT) Study Group. A randomised trial of anticoagulants versus aspirin after cerebral ischaemia of presumed arterial origin. Ann Neurol 1997;42:857-65.
25. Hess DC, Demchuk AM, Brass LM, et al. HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention. Neurology 2000:54:790-6.